The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Age-Associated Changes of Sirtuin 2 Expression in CNS and the Periphery
Abstract
Sirtuin 2 (SIRT2), one of the seven members of the sirtuin family, has emerged as a potential regulator of aging and age-related pathologies since several studies have demonstrated that it shows age-related changes in humans and different animal models. A detailed analysis of the relevant works published to date addressing this topic shows that the changes that occur in SIRT2 with aging seem to be opposite in the brain and in the periphery. On the one hand, aging induces an increase in SIRT2 levels in the brain, which supports the notion that its pharmacological inhibition is beneficial in different neurodegenerative diseases. However, on the other hand, in the periphery, SIRT2 levels are reduced with aging while keeping its expression is protective against age-related peripheral inflammation, insulin resistance, and cardiovascular diseases. Thus, systemic administration of any known modulator of this enzyme would have conflicting outcomes. This review summarizes the currently available information on changes in SIRT2 expression in aging and the underlying mechanisms affected, with the aim of providing evidence to determine whether its pharmacological modulation could be an effective and safe pharmacological strategy for the treatment of age-related diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“While SIRT2 is often linked to aging and longevity, its role in promoting or preventing aging remains a topic of debate (for a review, see (Garmendia-Berges et al., 2023).”
From Microglial SIRT2 deficiency aggravates cognitive decline and amyloid pathology in Alzheimer’s disease (2025) · cites this paper as Garmendia-Berges et al., 2023
In the citing paper
“SIRT2 has been identified as a key regulator of aging (Garmendia-Berges et al., 2023;Diaz-Perdigon et al., 2020)”
From Microglial SIRT2 deficiency aggravates cognitive decline and amyloid pathology in Alzheimer’s disease (2025) · cites this paper as Garmendia-Berges et al., 2023
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Promoting Health and Longevity through Diet: From Model Organisms to Humans
Fontana, L., & Partridge, L. (2015) · Cell · doi:10.1016/j.cell.2015.02.020 · Cited by 1,245
Undulating changes in human plasma proteome profiles across the lifespan
Lehallier, B., Gate, D., Schaum, N., Nanasi, T., Lee, S. E., Yousef, H., Moran Losada, P., Berdnik, D., Keller, A., Verghese, J., et al. (2019) · Nature Medicine · doi:10.1038/s41591-019-0673-2 · Cited by 981 · cited 1×
“Using a public proteome dataset researchers found that plasmatic SIRT2 is decreased with aging and is a valuable predictor of age-related aortic diseases in humans [23].”
BackgroundSirtuin functions and modulation: from chemistry to the clinic
Carafa, V., Rotili, D., Forgione, M., Cuomo, F., Serretiello, E., Hailu, G. S., Jarho, E., Lahtela-Kakkonen, M., Mai, A., & Altucci, L. (2016) · Clinical Epigenetics · doi:10.1186/s13148-016-0224-3 · Cited by 387
Luo, H., Mu, W.-C., Karki, R., Chiang, H.-H., Mohrin, M., Shin, J. J., Ohkubo, R., Ito, K., Kanneganti, T.-D., & Chen, D. (2019) · Cell Reports · doi:10.1016/j.celrep.2018.12.101 · Cited by 161 · cited 3×
“Again, they found a reduction in Sirt2 mRNA levels in old mice compared to the young ones [29].”
BackgroundResultInfluentialAcetylation regulates ribonucleotide reductase activity and cancer cell growth
Chen, G., Luo, Y., Warncke, K., Sun, Y., Yu, D. S., Fu, H., Behera, M., Ramalingam, S. S., Doetsch, P. W., Duong, D. M., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-11214-9 · Cited by 82 · cited 1×
“Moreover, it has been corroborated that SIRT2 participates in DNA replication, transcription, and RNA translation by deacetylating crucial substrates such as ATR kinase checkpoint [35], RNR [36], TIF-IB/SL1 [37], and eIF5A [38].”
BackgroundBahl, S., & Seto, E. (2021) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-020-03599-4 · Cited by 82 · cited 1×
“Sirtuins also Sirtuins also di ff er from other HDACs in their unique ability to catalyze ADP-ribosylation [5,6]. differ from other HDACs in their unique ability to catalyze ADP-ribosylation [5,6].”
BackgroundWhy Is Longevity Still a Scientific Mystery? Sirtuins—Past, Present and Future
Ziętara, P., Dziewięcka, M., & Augustyniak, M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms24010728 · Cited by 40
Research works printed but not linked: 100
- Wu, 2001, Genes, Genetics, and Epigenetics: A Correspondence, Science, 293, 1103, 10.1126/science.293.5532.1103 · DOI · Paper page
- Pagiatakis, 2021, Epigenetics of Aging and Disease: A Brief Overview, Aging Clin. Exp. Res., 33, 737, 10.1007/s40520-019-01430-0 · DOI
- Hamilton, 2011, Epigenetics: Principles and Practice, Dig. Dis., 29, 130, 10.1159/000323874 · DOI · Paper page
- Park, 2020, A Short Guide to Histone Deacetylases Including Recent Progress on Class II Enzymes, Exp. Mol. Med., 52, 204, 10.1038/s12276-020-0382-4 · DOI · Paper page
- Shoba, 2009, Function of Sirtuins in Biological Tissues, Anat. Rec., 292, 536, 10.1002/ar.20875 · DOI
- Sharma, A., Mahur, P., Muthukumaran, J., Singh, A.K., and Jain, M. (2023). Shedding Light on Structure, Function and Regulation of Human Sirtuins: A Comprehensive Review. 3 Biotech., 13. · DOI
- Chen, 2021, Sirtuin 2 (SIRT2): Confusing Roles in the Pathophysiology of Neurological Disorders, Front. Neurosci., 15, 614107, 10.3389/fnins.2021.614107 · DOI
- Wang, 2019, SIRT2: Controversy and Multiple Roles in Disease and Physiology, Ageing Res. Rev., 55, 100961, 10.1016/j.arr.2019.100961 · DOI · Paper page
- Wu, 2022, The Sirtuin Family in Health and Disease, Signal Transduct. Target. Ther., 7, 402, 10.1038/s41392-022-01257-8 · DOI · Paper page
- Liu, 2017, Loss of NAD-Dependent Protein Deacetylase Sirtuin-2 Alters Mitochondrial Protein Acetylation and Dysregulates Mitophagy, Antioxid. Redox Signal., 26, 849, 10.1089/ars.2016.6662 · DOI
- Shen, 2021, SIRT1: A Potential Therapeutic Target in Autoimmune Diseases, Front. Immunol., 12, 779177, 10.3389/fimmu.2021.779177 · DOI · Paper page
- Manjula, R., Anuja, K., and Alcain, F.J. (2021). SIRT1 and SIRT2 Activity Control in Neurodegenerative Diseases. Front. Pharmacol., 11. · DOI · Paper page
- Yang, 2022, SIRT6 Mediates Multidimensional Modulation to Maintain Organism Homeostasis, J. Cell Physiol., 237, 3205, 10.1002/jcp.30791 · DOI
- Tong, 2016, SIRT7 Is Activated by DNA and Deacetylates Histone H3 in the Chromatin Context, ACS Chem. Biol., 11, 742, 10.1021/acschembio.5b01084 · DOI
- Ji, 2022, Mitochondrial Sirtuins, Metabolism, and Aging, J. Genet. Genom., 49, 287, 10.1016/j.jgg.2021.11.005 · DOI · Paper page
- Zhu, 2022, Multiple Roles of SIRT2 in Regulating Physiological and Pathological Signal Transduction, Genet. Res., 2022, 9282484, 10.1155/2022/9282484 · DOI
- Chambers, S.M., Shaw, C.A., Gatza, C., Fisk, C.J., Donehower, L.A., and Goodell, M.A. (2007). Aging Hematopoietic Stem Cells Decline in Function and Exhibit Epigenetic Dysregulation. PLoS Biol., 5. · DOI · Paper page
- Anwar, 2016, Increased Expression of SIRT2 Is a Novel Marker of Cellular Senescence and Is Dependent on Wild Type P53 Status, Cell Cycle, 15, 1883, 10.1080/15384101.2016.1189041 · DOI
- Braidy, 2015, Differential Expression of Sirtuins in the Aging Rat Brain, Front. Cell Neurosci., 9, 167, 10.3389/fncel.2015.00167 · DOI
- Maxwell, 2011, The Sirtuin 2 Microtubule Deacetylase Is an Abundant Neuronal Protein That Accumulates in the Aging CNS, Hum. Mol. Genet., 20, 3986, 10.1093/hmg/ddr326 · DOI · Paper page
- Belloch, 2020, Early Sirtuin 2 Inhibition Prevents Age-Related Cognitive Decline in a Senescence-Accelerated Mouse Model, Neuropsychopharmacology, 45, 347, 10.1038/s41386-019-0503-8 · DOI · Paper page
- Akbulut, 2022, SIRT2 and FOXO3a Expressions in the Cerebral Cortex and Hippocampus of Young and Aged Male Rats: Antioxidant and Anti-Apoptotic Effects of Melatonin, Biol. Futur., 73, 71, 10.1007/s42977-021-00102-3 · DOI
- Wongchitrat, 2019, Alterations in the Expression of Amyloid Precursor Protein Cleaving Enzymes MRNA in Alzheimer Peripheral Blood, Curr. Alzheimer Res., 16, 29, 10.2174/1567205015666181109103742 · DOI
- Ye, 2023, SIRT2 Counteracts Primate Cardiac Aging via Deacetylation of STAT3 That Silences CDKN2B, Nat. Aging, 3, 1269, 10.1038/s43587-023-00486-y · DOI
- North, 2003, The Human Sir2 Ortholog, SIRT2, Is an NAD+-Dependent Tubulin Deacetylase, Mol. Cell, 11, 437, 10.1016/S1097-2765(03)00038-8 · DOI · Paper page
- Vaquero, 2006, SirT2 Is a Histone Deacetylase with Preference for Histone H4 Lys 16 during Mitosis, Genes Dev., 20, 1256, 10.1101/gad.1412706 · DOI · Paper page
- Michan, 2007, Sirtuins in Mammals: Insights into Their Biological Function, Biochem. J., 404, 1, 10.1042/BJ20070140 · DOI · Paper page
- Zhang, 2020, The Clinical Significance of SIRT2 in Malignancies: A Tumor Suppressor or an Oncogene?, Front. Oncol., 10, 1721, 10.3389/fonc.2020.01721 · DOI
- Zhang, 2016, ATRIP Deacetylation by SIRT2 Drives ATR Checkpoint Activation by Promoting Binding to RPA-SsDNA, Cell Rep., 14, 1435, 10.1016/j.celrep.2016.01.018 · DOI
- Muth, 2001, Acetylation of TAF(I)68, a Subunit of TIF-IB/SL1, Activates RNA Polymerase I Transcription, EMBO J., 20, 1353, 10.1093/emboj/20.6.1353 · DOI · Paper page
- Ishfaq, 2012, Acetylation Regulates Subcellular Localization of Eukaryotic Translation Initiation Factor 5A (EIF5A), FEBS Lett., 586, 3236, 10.1016/j.febslet.2012.06.042 · DOI
- Cha, 2017, Metabolic Control of Primed Human Pluripotent Stem Cell Fate and Function by the MiR-200c-SIRT2 Axis, Nat. Cell Biol., 19, 445, 10.1038/ncb3517 · DOI · Paper page
- Zhao, 2013, Lysine-5 Acetylation Negatively Regulates Lactate Dehydrogenase A and Is Decreased in Pancreatic Cancer, Cancer Cell, 23, 464, 10.1016/j.ccr.2013.02.005 · DOI · Paper page
- Gomes, 2015, Emerging Role of Sirtuin 2 in the Regulation of Mammalian Metabolism, Trends Pharmacol. Sci., 36, 756, 10.1016/j.tips.2015.08.001 · DOI · Paper page
- Zhang, 2022, Quantitative Proteomic Analysis of the Lysine Acetylome Reveals Diverse SIRT2 Substrates, Sci. Rep., 12, 3822, 10.1038/s41598-022-06793-5 · DOI
- Crocco, 2016, Polymorphisms Falling Within Putative MiRNA Target Sites in the 3’UTR Region of SIRT2 and DRD2 Genes Are Correlated With Human Longevity, J. Gerontol. Ser. A Biol. Sci. Med. Sci., 71, 586, 10.1093/gerona/glv058 · DOI
- He, 2020, An Acetylation Switch of the NLRP3 Inflammasome Regulates Aging-Associated Chronic Inflammation and Insulin Resistance, Cell Metab., 31, 580, 10.1016/j.cmet.2020.01.009 · DOI · Paper page
- Sola-Sevilla, N., Ricobaraza, A., Hernandez-Alcoceba, R., Aymerich, M.S., Tordera, R.M., and Puerta, E. (2021). Understanding the Potential Role of Sirtuin 2 on Aging: Consequences of SIRT2.3 Overexpression in Senescence. Int. J. Mol. Sci., 22. · DOI
- Wang, 2012, Deacetylation of FOXO3 by SIRT1 or SIRT2 Leads to Skp2-Mediated FOXO3 Ubiquitination and Degradation, Oncogene, 31, 1546, 10.1038/onc.2011.347 · DOI · Paper page
- Wang, 2007, SIRT2 Deacetylates FOXO3a in Response to Oxidative Stress and Caloric Restriction, Aging Cell, 6, 505, 10.1111/j.1474-9726.2007.00304.x · DOI · Paper page
- 2014, Oxidative Stress Activates the Transcription Factors FoxO 1a and FoxO 3a in the Hippocampus of Rats Exposed to Low Doses of Ozone, Oxid. Med. Cell Longev., 2014, 805764
- Lynn, 2008, SIRT2 Is a Negative Regulator of Anoxia–Reoxygenation Tolerance via Regulation of 14-3-3 ζ and BAD in H9c2 Cells, FEBS Lett., 582, 2857, 10.1016/j.febslet.2008.07.016 · DOI
- Nie, 2014, SIRT2 Mediates Oxidative Stress-Induced Apoptosis of Differentiated PC12 Cells, Neuroreport, 25, 838, 10.1097/WNR.0000000000000192 · DOI
- Sarikhani, 2018, SIRT2 Regulates Oxidative Stress-Induced Cell Death through Deacetylation of c-Jun NH2-Terminal Kinase, Cell Death Differ., 25, 1638, 10.1038/s41418-018-0069-8 · DOI
- She, 2018, SIRT2 Inhibition Confers Neuroprotection by Downregulation of FOXO3a and MAPK Signaling Pathways in Ischemic Stroke, Mol. Neurobiol., 55, 9188, 10.1007/s12035-018-1058-0 · DOI
- Pino, 2014, FOXO3 Determines the Accumulation of α-Synuclein and Controls the Fate of Dopaminergic Neurons in the Substantia Nigra, Hum. Mol. Genet., 23, 1435, 10.1093/hmg/ddt530 · DOI
- Qin, 2008, Regulation of Forkhead Transcription Factor FoxO3a Contributes to Calorie Restriction-Induced Prevention of Alzheimer’s Disease-Type Amyloid Neuropathology and Spatial Memory Deterioration, Ann. N.Y. Acad. Sci., 1147, 335, 10.1196/annals.1427.024 · DOI
- Garg, 2017, Antiaging Effect of Metformin on Brain in Naturally Aged and Accelerated Senescence Model of Rat, Rejuvenation Res., 20, 173, 10.1089/rej.2016.1883 · DOI · Paper page
- Gal, 2012, SIRT2 Interferes with Autophagy-Mediated Degradation of Protein Aggregates in Neuronal Cells under Proteasome Inhibition, Neurochem. Int., 61, 992, 10.1016/j.neuint.2012.07.010 · DOI
- Inoue, 2014, SIRT2 Knockdown Increases Basal Autophagy and Prevents Postslippage Death by Abnormally Prolonging the Mitotic Arrest That Is Induced by Microtubule Inhibitors, FEBS J., 281, 2623, 10.1111/febs.12810 · DOI
- Li, 2023, Cooperative Effects of SIRT1 and SIRT2 on APP Acetylation, Aging Cell, 22, e13967, 10.1111/acel.13967 · DOI
- Kireev, 2013, Growth Hormone and Melatonin Prevent Age-Related Alteration in Apoptosis Processes in the Dentate Gyrus of Male Rats, Biogerontology, 14, 431, 10.1007/s10522-013-9443-6 · DOI
- Yudoh, 2015, Age-Related Decrease of Sirtuin 2 Protein in Human Peripheral Blood Mononuclear Cells, Curr. Aging Sci., 8, 256, 10.2174/1874609808999150831112939 · DOI · Paper page
- Zhang, 2023, Sirtuin 2 Deficiency Aggravates Ageing-Induced Vascular Remodelling in Humans and Mice, Eur. Heart J., 44, 2746, 10.1093/eurheartj/ehad381 · DOI · Paper page
- North, 2014, SIRT2 Induces the Checkpoint Kinase BubR1 to Increase Lifespan, EMBO J., 33, 1438, 10.15252/embj.201386907 · DOI · Paper page
- (2022). 2022 Alzheimer’s Disease Facts and Figures. Alzheimer’s Dement., 18, 700–789. · DOI · Paper page
- Aleixo, 2023, SIRT2 Inhibition Rescues Neurodegenerative Pathology but Increases Systemic Inflammation in a Transgenic Mouse Model of Alzheimer’s Disease, J. Neuroimmune Pharmacol., 18, 529, 10.1007/s11481-023-10084-9 · DOI · Paper page
- Silva, 2017, Mitochondrial Metabolism Power SIRT2-Dependent Deficient Traffic Causing Alzheimer’s-Disease Related Pathology, Mol. Neurobiol., 54, 4021, 10.1007/s12035-016-9951-x · DOI
- Singh, 2017, Sirtuin-2 Protects Neural Cells from Oxidative Stress and Is Elevated in Neurodegeneration, Parkinsons Dis., 2017, 1, 10.1155/2017/2643587 · DOI
- Yun, 2021, Inhibitor of DNA Binding 2 (Id2) Mediates Microtubule Polymerization in the Brain by Regulating AK40 Acetylation of α-Tubulin, Cell Death Discov., 7, 257, 10.1038/s41420-021-00652-4 · DOI
- Gaetani, L., Bellomo, G., Parnetti, L., Blennow, K., Zetterberg, H., and Di Filippo, M. (2021). Neuroinflammation and Alzheimer’s Disease: A Machine Learning Approach to CSF Proteomics. Cells, 10. · DOI
- Puerta, 2024, SIRT2 as a Potential New Therapeutic Target for Alzheimer’s Disease, Neural Regen. Res., 19, 125
- Biella, 2016, Sirtuin 2 Inhibition Improves Cognitive Performance and Acts on Amyloid-β Protein Precursor Processing in Two Alzheimer’s Disease Mouse Models, J. Alzheimer’s Dis., 53, 1193, 10.3233/JAD-151135 · DOI · Paper page
- Wang, 2020, RTN4B-Mediated Suppression of Sirtuin 2 Activity Ameliorates β-Amyloid Pathology and Cognitive Impairment in Alzheimer’s Disease Mouse Model, Aging Cell, 19, e13194, 10.1111/acel.13194 · DOI · Paper page
- Bai, 2022, Inhibition of SIRT2 Promotes APP Acetylation and Ameliorates Cognitive Impairment in APP/PS1 Transgenic Mice, Cell Rep., 40, 111062, 10.1016/j.celrep.2022.111062 · DOI · Paper page
- Moore, 2005, Molecular Pathophysiology of Parkinson’s Disease, Annu. Rev. Neurosci., 28, 57, 10.1146/annurev.neuro.28.061604.135718 · DOI · Paper page
- Shihabuddin, 2018, New Frontiers in Parkinson’s Disease: From Genetics to the Clinic, J. Neurosci., 38, 9375, 10.1523/JNEUROSCI.1666-18.2018 · DOI
- Wang, 2015, Aging-Related Rotenone-Induced Neurochemical and Behavioral Deficits: Role of SIRT2 and Redox Imbalance, and Neuroprotection by AK-7, Drug Des. Devel Ther., 9, 2553, 10.2147/DDDT.S81539 · DOI
- Guan, 2016, Aging-Related 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine-Induced Neurochemial and Behavioral Deficits and Redox Dysfunction: Improvement by AK-7, Exp. Gerontol., 82, 19, 10.1016/j.exger.2016.05.011 · DOI
- Sun, 2018, MicroRNA-212-5p Prevents Dopaminergic Neuron Death by Inhibiting SIRT2 in MPTP-Induced Mouse Model of Parkinson’s Disease, Front. Mol. Neurosci., 11, 381, 10.3389/fnmol.2018.00381 · DOI · Paper page
- Chen, X., Mai, H., Chen, X., Cai, Y., Cheng, Q., Chen, X., Li, X., Fan, W., Tang, P., and Ou, M. (2019). Rs2015 Polymorphism in MiRNA Target Site of Sirtuin2 Gene Is Associated with the Risk of Parkinson’s Disease in Chinese Han Population. Biomed. Res. Int., 2019. · DOI
- Chen, X., Wales, P., Quinti, L., Zuo, F., Moniot, S., Herisson, F., Rauf, N.A., Wang, H., Silverman, R.B., and Ayata, C. (2015). The Sirtuin-2 Inhibitor AK7 Is Neuroprotective in Models of Parkinson’s Disease but Not Amyotrophic Lateral Sclerosis and Cerebral Ischemia. PLoS ONE, 10. · DOI
- Esteves, 2018, Mitochondrial Metabolism Regulates Microtubule Acetylome and Autophagy Trough Sirtuin-2: Impact for Parkinson’s Disease, Mol. Neurobiol., 55, 1440, 10.1007/s12035-017-0420-y · DOI
- Yan, 2022, Cdk5 Phosphorylation-Induced SIRT2 Nuclear Translocation Promotes the Death of Dopaminergic Neurons in Parkinson’s Disease, NPJ Parkinsons Dis., 8, 46, 10.1038/s41531-022-00311-0 · DOI
- Outeiro, 2007, Sirtuin 2 Inhibitors Rescue Alpha-Synuclein-Mediated Toxicity in Models of Parkinson’s Disease, Science, 317, 516, 10.1126/science.1143780 · DOI · Paper page
- Zacharioudakis, 2015, The Discovery of a Highly Selective 5,6,7,8-Tetrahydrobenzo[4,5]Thieno[2,3-d]Pyrimidin-4(3H)-One SIRT2 Inhibitor That Is Neuroprotective in an in Vitro Parkinson’s Disease Model, ChemMedChem, 10, 69, 10.1002/cmdc.201402431 · DOI
- De Oliveira, R.M., Vicente Miranda, H., Francelle, L., Pinho, R., Szegö, É.M., Martinho, R., Munari, F., Lázaro, D.F., Moniot, S., and Guerreiro, P. (2017). The Mechanism of Sirtuin 2-Mediated Exacerbation of Alpha-Synuclein Toxicity in Models of Parkinson Disease. PLoS Biol., 15. · DOI
- Li, 2016, MicroRNA-7 Inhibits Neuronal Apoptosis in a Cellular Parkinson’s Disease Model by Targeting Bax and Sirt2, Am. J. Transl. Res., 8, 993
- Wang, 2018, MiR-486-3p Influences the Neurotoxicity of a-Synuclein by Targeting the SIRT2 Gene and the Polymorphisms at Target Sites Contributing to Parkinson’s Disease, Cell Physiol. Biochem., 51, 2732, 10.1159/000495963 · doi:10.1159/000495963
- Young, 2003, Huntingtin in Health and Disease, J. Clin. Investig., 111, 299, 10.1172/JCI17742 · DOI
- Baldo, 2019, SIRT1 Is Increased in Affected Brain Regions and Hypothalamic Metabolic Pathways Are Altered in Huntington Disease, Neuropathol. Appl. Neurobiol., 45, 361, 10.1111/nan.12514 · DOI
- Taylor, 2010, SIRT2 Inhibition Achieves Neuroprotection by Decreasing Sterol Biosynthesis, Proc. Natl. Acad. Sci. USA, 107, 7927, 10.1073/pnas.1002924107 · DOI · Paper page
- Chopra, 2012, The Sirtuin 2 Inhibitor AK-7 Is Neuroprotective in Huntington’s Disease Mouse Models, Cell Rep., 2, 1492, 10.1016/j.celrep.2012.11.001 · DOI · Paper page
- Pallos, 2008, Inhibition of Specific HDACs and Sirtuins Suppresses Pathogenesis in a Drosophila Model of Huntington’s Disease, Hum. Mol. Genet., 17, 3767, 10.1093/hmg/ddn273 · DOI · Paper page
- Quinti, 2016, SIRT2- and NRF2-Targeting Thiazole-Containing Compound with Therapeutic Activity in Huntington’s Disease Models, Cell Chem. Biol., 23, 849, 10.1016/j.chembiol.2016.05.015 · DOI
- Taylor, 2011, A Brain-Permeable Small Molecule Reduces Neuronal Cholesterol by Inhibiting Activity of Sirtuin 2 Deacetylase, ACS Chem. Biol., 6, 540, 10.1021/cb100376q · DOI
- Bobrowska, A., Donmez, G., Weiss, A., Guarente, L., and Bates, G. (2012). SIRT2 Ablation Has No Effect on Tubulin Acetylation in Brain, Cholesterol Biosynthesis or the Progression of Huntington’s Disease Phenotypes in Vivo. PLoS ONE, 7. · DOI
- Liscic, 2020, From Basic Research to the Clinic: Innovative Therapies for ALS and FTD in the Pipeline, Mol. Neurodegener., 15, 31, 10.1186/s13024-020-00373-9 · DOI
- Valle, 2014, Tissue-Specific Deregulation of Selected HDACs Characterizes ALS Progression in Mouse Models: Pharmacological Characterization of SIRT1 and SIRT2 Pathways, Cell Death Dis., 5, e1296, 10.1038/cddis.2014.247 · DOI
- Taes, 2013, Hdac6 Deletion Delays Disease Progression in the SOD1G93A Mouse Model of ALS, Hum. Mol. Genet., 22, 1783, 10.1093/hmg/ddt028 · DOI
- Banerjee, 2022, NLRP3 Inflammasome as a Key Molecular Target Underlying Cognitive Resilience in Amyotrophic Lateral Sclerosis, J. Pathol., 256, 262, 10.1002/path.5846 · DOI
- Fusco, R., Siracusa, R., Genovese, T., Cuzzocrea, S., and Di Paola, R. (2020). Focus on the Role of NLRP3 Inflammasome in Diseases. Int. J. Mol. Sci., 21. · DOI · Paper page
- Malhotra, 2021, Targeting Inflammasomes to Treat Neurological Diseases, Ann. Neurol., 90, 177, 10.1002/ana.26158 · DOI
- Zhou, 2018, Recent Advances in Inhibitors of Sirtuin1/2: An Update and Perspective, Future Med. Chem., 10, 907, 10.4155/fmc-2017-0207 · DOI
- Suzuki, 2012, Design, Synthesis, and Biological Activity of a Novel Series of Human Sirtuin-2-Selective Inhibitors, J. Med. Chem., 55, 5760, 10.1021/jm3002108 · DOI
- Erburu, 2017, SIRT2 Inhibition Modulate Glutamate and Serotonin Systems in the Prefrontal Cortex and Induces Antidepressant-like Action, Neuropharmacology, 117, 195, 10.1016/j.neuropharm.2017.01.033 · DOI · Paper page
- Sakai, 2015, Design, Synthesis and Structure–Activity Relationship Studies of Novel Sirtuin 2 (SIRT2) Inhibitors with a Benzamide Skeleton, Bioorganic Med. Chem., 23, 328, 10.1016/j.bmc.2014.11.027 · DOI
- Yeong, K.Y., Khaw, K.Y., Takahashi, Y., Itoh, Y., Murugaiyah, V., and Suzuki, T. (2020). Discovery of Gamma-Mangostin from Garcinia Mangostana as a Potent and Selective Natural SIRT2 Inhibitor. Bioorganic Chem., 94. · DOI
- Singh, 2021, Design and in Vitro Analysis of SIRT2 Inhibitor Targeting Parkinson’s Disease, Mol. Divers., 25, 2261, 10.1007/s11030-020-10116-z · DOI
- Djokovic, N., Rahnasto-Rilla, M., Lougiakis, N., Lahtela-Kakkonen, M., and Nikolic, K. (2023). SIRT2i_Predictor: A Machine Learning-Based Tool to Facilitate the Discovery of Novel SIRT2 Inhibitors. Pharmaceuticals, 16. · DOI
Cited by
Sola-Sevilla, N., Garmendia-Berges, M., Aleixo, M., Mera-Delgado, M., Solas, M., Tordera, R. M., García-Carracedo, L., Expósito, S., Anaya-Cubero, E., Fernández-Irigoyen, J., et al. (2025) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2025.06.016 · Cited by 5
Self-citation
Metadata
- Authors
- Garmendia-Berges, M., Sola-Sevilla, N., Mera-Delgado, M., & Puerta, E.
- Affiliations
- Pharmaceutical Sciences Department, Division of Pharmacology, School of Pharmacy and Nutrition, University of Navarra, 31008 Pamplona, Spain
- Venue
- Biology
- Publisher
- MDPI AG
- Published
- 2023-11-29
- Volume
- 12
- Issue
- 12
- Pages
- 1476
- ISSN
- 2079-7737
- Cited by
- 9
- References
- 7
- Language
- en
- Funders
- FEDER/Ministerio de Ciencia, Innovación y Universidades Agencia Estatal de Investigación/ Project (PID2020-119729GB-100, REF/AEI/10.13039/501100011033)
- Spanish Ministry of Universities (FPU) (PID2020-119729GB-100, REF/AEI/10.13039/501100011033)
- Programa MRR Investigo 2023 (PID2020-119729GB-100, REF/AEI/10.13039/501100011033)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Age-Associated Changes of Sirtuin 2 Expression in CNS and the Periphery. https://app.cochat.ai/papers/10.3390/biology12121476
- The paper
- Garmendia-Berges, M., Sola-Sevilla, N., Mera-Delgado, M., & Puerta, E. (2023). Age-Associated Changes of Sirtuin 2 Expression in CNS and the Periphery. Biology. https://doi.org/10.3390/biology12121476
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.